Lataa...
Lenalidomide-Induced Immunomodulation in Multiple Myeloma: Impact on Vaccines and Antitumor Responses
PURPOSE: To show that the immunomodulatory drug lenalidomide can be used in patients with relapsed multiple myeloma to augment vaccine responses. EXPERIMENTAL DESIGN: Early phase clinical trial of patients with multiple myeloma who received at least one prior therapy. Patients were treated with sing...
Tallennettuna:
| Päätekijät: | , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3640365/ https://ncbi.nlm.nih.gov/pubmed/22241792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-11-1221 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|